Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Monogram Orthopaedics Inc ( (MGRM) ) has shared an announcement.
Monogram Technologies Inc. informed its stockholders on July 31, 2025, about the availability of a FAQs section on its Investor Relations page, which addresses the proposed acquisition by Zimmer Biomet Holdings, Inc. This follows the initial announcement of the acquisition on July 14, 2025, and aims to provide clarity to stakeholders regarding the transaction.
The most recent analyst rating on (MGRM) stock is a Buy with a $4.00 price target. To see the full list of analyst forecasts on Monogram Orthopaedics Inc stock, see the MGRM Stock Forecast page.
Spark’s Take on MGRM Stock
According to Spark, TipRanks’ AI Analyst, MGRM is a Neutral.
Monogram Orthopaedics Inc. shows promise due to significant technological advancements and recent regulatory clearances, which are key drivers for potential growth. However, financial instability, regulatory uncertainties, and ongoing profitability challenges weigh heavily on the overall score. The stock’s upward momentum is a positive indicator, but valuation metrics remain weak due to negative earnings and lack of dividends.
To see Spark’s full report on MGRM stock, click here.
More about Monogram Orthopaedics Inc
Average Trading Volume: 341,771
Technical Sentiment Signal: Buy
See more data about MGRM stock on TipRanks’ Stock Analysis page.